Endometriosis

Yen & Jaffe's Reproductive Endocrinology

Volumn , Issue , 2009, Pages 577-595

  Taylor, Robert N ^a   Lebovic, Dan I ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884012710     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-4907-4.00024-3     Document Type: Chapter

References (306)

1. Eskenazi B., Warner M. Epidemiology of endometriosis. Obstet Gynecol Clin North Am 1997, 24:235-258.
2. Weaver F., Hynes D., Goldberg J.M., et al. Hysterectomy in Veterans affairs medical centers. Obstet Gynecol 2001, 97:880-884.
3. MacDonald S.R., Klock S.C., Milad M.P. Long-term outcome of nonconservative surgery (hysterectomy) for endometriosis-associated pain in women <30 years old. Am J Obstet Gynecol 1999, 180:1360-1363.
4. Simoens S., Hummelshoj L. D'Hooghe T. Endometriosis: cost estimates and methodological perspective. Hum Reprod Update 2007, 13:395-404.
5. Knapp V. How old is endometriosis? Late 17th- and 18th-century European descriptions of the disease. Fertil Steril 1999, 72:10-14.
6. Brosens I., Steeno O. Letter to the editor. Fertil Steril 2000, 73:179-180.
7. Russell W. Aberrant portions of the müllerian duct found in an ovary. Johns Hopkins Hosp Bull 1899, 10:8-10.
8. Sampson J. Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol 1927, 14:422-469.
9. Halban J. Hysteroadenosis metastatica. Zentralb Gynäkol 1925, 7:387-391.
10. Thibodeau L., Prioleau G.R., Manuelidis E.E., et al. Cerebral endometriosis. case report. J Neurosurg 1987, 66:609-610.
11. Laghzaoui O., Laghzaoui M. [Nasal endometriosis: apropos of 1 case]. J Gynecol Obstet Biol Reprod (Paris) 2001, 30:786-788.
12. Halme J., Hammond M., Hulka J., et al. Retrograde menstruation in healthy women and in patients with endometriosis. Obstet Gynecol 1984, 64:151-154.
13. Kruitwagen R., Poels L., Willemsen W., et al. Endometrial epithelial cells in peritoneal fluid during the early follicular phase. Fertil Steril 1991, 55:297-303.
14. Flores I., Rivera E., Ruiz L.A., et al. Molecular profiling of experimental endometriosis identified gene expression patterns in common with human disease. Fertil Steril 2007, 87:1180-1199.
15. Bulletti C., DeZiegler D., Stefanetti M., et al. Endometriosis: absence of recurrence in patients after endometrial ablation. Hum Reprod 2001, 16:2676-2679.
16. Vercellini P., Aimi G., De Giorgi O., et al. Is cystic ovarian endometriosis an asymmetric disease?. Br J Obstet Gynaecol 1998, 105:1018-1021.
17. Redwine D. Was Sampson wrong?. Fertil Steril 2002, 78:686-693.
18. Witz C., Thomas M., Montoya-Rodriguez I., et al. Short-term culture of peritoneum explants confirms attachment of endometrium to intact peritoneal mesothelium. Fertil Steril 2001, 75:385-390.
19. Witz C.A., Monotoya-Rodriguez I.A., Schenken R.S. Whole explants of peritoneum and endometrium: a novel model of the early endometriosis lesion. Fertil Steril 1999, 71:56-60.
20. Nisolle M., Donnez J. Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entities. Fertil Steril 1997, 68:585-596.
21. Meyer R. Zur Frage der heterotopen Epithelwucherung, insbesondere des Peritonealepithels und in die Ovarien. Virch Arch Path Anat Phys 1924, 250:595-610.
22. Zheng W., Li N., Wang J., et al. Initial endometriosis showing direct morphologic evidence of metaplasia in the pathogenesis of ovarian endometriosis. Int J Gynecol Pathol 2005, 24:164-172.
23. Leyendecker G., Kunz G., Noe M., et al. Endometriosis: a dysfunction and disease of the archimetra. Hum Reprod Update 1998, 4:752-762.
24. Gargett C.E. Stem cells in gynaecology. Aust N Z J Obstet Gynaecol 2004, 44:380-386.
25. Taylor H.S. Endometrial cells derived from donor stem cells in bone marrow transplant recipients. JAMA 2004, 292:81-85.
26. Barbieri R. Hormone treatment of endometriosis: the estrogen threshold hypothesis. Am J Obstet Gynecol 1992, 166:740-745.
27. Malinak L., Buttram V.J., Elias S., et al. Heritage aspects of endometriosis. II. Clinical characteristics of familial endometriosis. Am J Obstet Gynecol 1980, 137:332-337.
28. Missmer S.A., Hankinson S.E., Spiegelman D., et al. Reproductive history and endometriosis among premenopausal women. Obstet Gynecol 2004, 104:965-974.
29. Rier S., Martin D.C., Bowman R.E., et al. Endometriosis in rhesus monkeys (Macaca mulatta) following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Fundam Appl Toxicol 1993, 21:433-441.
30. Koninckx P., Braet P., Kennedy S., et al. Dioxin pollution and endometriosis in Belgium. Hum Reprod 1994, 9:1001-1002.
31. Birnbaum L., Cummings A. Dioxins and endometriosis: a plausible hypothesis. Environ Health Perspect 2002, 110:15-21.
32. Pauwels A., Schepens P.J., D'Hooghe T., et al. The risk of endometriosis and exposure to dioxins and polychlorinated biphenyls: a case-control study of infertile women. Hum Reprod 2001, 16:2050-2055.
33. Heilier J.F., Nackers F., Verougstraete V., et al. Increased dioxin-like compounds in the serum of women with peritoneal endometriosis and deep endometriotic (adenomyotic) nodules. Fertil Steril 2005, 84:305-312.
34. Nayyar T., Bruner-Tran K.L., Piestrzeniewicz-Ulanska D., et al. Developmental exposure of mice to TCDD elicits a similar uterine phenotype in adult animals as observed in women with endometriosis. Reprod Toxicol 2007, 23:326-336.
35. Treloar S., O'Connor D., O'Connor V., et al. Genetic influences on endometriosis in an Australian twin sample. Fertil Steril 1999, 71:701-710.
36. Simpson J., Elias S., Malinak L., et al. Heritable aspects of endometriosis: genetic studies. Am J Obstet Gynecol 1980, 137:327-331.
37. Kennedy S., Mardon H., Barlow D. Familial endometriosis. J Assist Reprod Genet 1995, 12:32-34.
38. Stefansson H., Geirsson R., Steinthorsdottir V., et al. Genetic factors contribute to the risk of developing endometriosis. Hum Reprod 2002, 17:555-559.
39. Treloar S.A., Wicks J., Nyholt D.R., et al. Genomewide linkage study in 1,176 affected sister pair families identifies a significant susceptibility locus for endometriosis on chromosome 10q26. Am J Hum Genet 2005, 77:365-376.
40. Kao L., Tulac S., Lobo S., et al. Gene profiling in human endometrium during the window of implantation. Endocrinology 2002, 143:2119-2138.
41. Burney R.O., Talbi S., Hamilton A.E., et al. Gene expression analysis of endometrium reveals progesterone resistance and candidate susceptibility genes in women with endometriosis. Endocrinology 2007, 148:3814-3826.
42. Wu Y., Kajdacsy-Balla A., Strawn E., et al. Transcriptional characterizations of differences between eutopic and ectopic endometrium. Endocrinology 2006, 147:232-246.
43. Taylor R., Lundeen S., Giudice L. Emerging role of genomics in endometriosis research. Fertil Steril 2002, 78:694-698.
44. Liang P., Pardee A.B. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 1992, 257:967-971.
45. Lundeen S, Lebovic D, Carver J, et al. Differential display PCR analysis of gene expression in eutopic and ectopic endometrial tissues. Presented at the VII World Congress on Endometriosis, London, May 2000 London, England. Report No.: #27.
46. Lebovic D., Baldocchi R.A., Mueller M.D., Taylor R.N. Altered expression of a cell-cycle suppressor gene, Tob-1, in endometriotic cells by cDNA array analyses. Fertil Steril 2002, 78:849-854.
47. Slichenmyer W., Fry D.W. Anticancer therapy targeting the erbB family of receptor tyrosine kinases. Semin Oncol 2001, 28:67-79.
48. Rossi M., Sharkey A.M., Vigano P., et al. Identification of genes regulated by interleukin-1beta in human endometrial stromal cells. Reproduction 2005, 130:721-729.
49. Pan Q., Luo X., Toloubeydokhti T., et al. The expression profile of micro-RNA in endometrium and endometriosis and the influence of ovarian steroids on their expression. Mol Hum Reprod 2007, 13:797-806.
50. Kosugi Y., Elias S., Malinak L., et al. Increased heterogeneity of chromosome 17 aneuploidy in endometriosis. Am J Obstet Gynecol 1999, 180:792-797.
51. Bischoff F., Heard M., Simpson J. Somatic DNA alterations in endometriosis: high frequency of chromosome 17 and p53 loss in late-stage endometriosis. J Reprod Immunol 2002, 55:49-64.
52. Gogusev J., Bouquet de Joliniere J., Telvi L., et al. Detection of DNA copy number changes in human endometriosis by comparative genomic hybridization. Hum Genet 1999, 105:444-451.
53. Campbell I., Thomas E. Endometriosis: candidate genes. Hum Reprod Upd 2001, 7:15-20.
54. Gogusev J., Bouquet de Joliniere J., Telvi L., et al. Genetic abnormalities detected by comparative genomic hybridization in a human endometriosis-derived cell line. Mol Hum Reprod 2000, 6:821-827.
55. Nakago S., Hadfield R.M., Zondervan K.T., et al. Association between endometriosis and N-acetyl transferase 2 polymorphisms in a UK population. Mol Hum Reprod 2001, 7:1079-1083.
56. Cramer D.W., Goldstein D.P., Fraer C., et al. Vaginal agenesis (Mayer-Rokitansky-Kuster-Hauser syndrome) associated with the N314D mutation of galactose-1-phosphate uridyl transferase (GALT). Mol Hum Reprod 1996, 2:145-148.
57. Cramer D., Hornstein M., Ng W., et al. Endometriosis associated with the N314D mutation of galactose-1-phosphate uridyl transferase (GALT). Mol Hum Reprod 1996, 2:149-152.
58. Stefansson H., Einarsdottir A., Geirsson R.T., et al. Endometriosis is not associated with or linked to the GALT gene. Fertil Steril 2001, 76:1019-1022.
59. Viganò P., Infantino M., Ponti E., et al. Analysis of G/R241 intercellular adhesion molecule-1 (ICAM-1) gene polymorphism in a group of Italian endometriosis patients. Fertil Steril 2002, 77(Suppl 1):S20.
60. Baranova H., Canis M., Ivaschenko T., et al. Possible involvement of arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1 genes in the development of endometriosis. Mol Hum Reprod 1999, 5:636-641.
61. Hadfield R.M., Manek S., Weeks D.E., et al. Linkage and association studies of the relationship between endometriosis and genes encoding the detoxification enzymes GSTM1, GSTT1 and CYP1A1. Mol Hum Reprod 2001, 7:1073-1078.
62. Gentilini D., Somigliana E., Vigano P., et al. The vascular endothelial growth factor +405G>C polymorphism in endometriosis. Hum Reprod 2008, 23. 211-115.
63. Kitawaki J., Obayashi H., Ishihara H., et al. Oestrogen receptor-alpha gene polymorphism is associated with endometriosis, adenomyosis and leiomyomata. Hum Reprod 2001, 16(1):51-55.
64. Wieser F., Schneeberger C., Tong D., et al. PROGINS receptor gene polymorphism is associated with endometriosis. Fertil Steril 2002, 77:309-312.
65. Attia G., Zeitoun K., Edwards D., et al. Progesterone receptor isoform A but not B is expressed in endometriosis. J Clin Endocrinol Metab 2000, 85:2897-2902.
66. Xue Q., Lin Z., Cheng Y.H., et al. Promoter methylation regulates estrogen receptor 2 in human endometrium and endometriosis. Biol Reprod 2007, 77:681-687.
67. Wu Y., Halverson G., Basir Z., et al. Aberrant methylation at HOXA10 may be responsible for its aberrant expression in the endometrium of patients with endometriosis. Am J Obstet Gynecol 2005, 193:371-380.
68. Kim J.J., Taylor H.S., Lu Z., et al. Altered expression of HOXA10 in endometriosis: potential role in decidualization. Mol Hum Reprod 2007, 13:323-332.
69. Anaf V., Simon P., El Nakadi I., et al. Hyperalgesia, nerve infiltration and nerve growth factor expression in deep adenomyotic nodules, peritoneal and ovarian endometriosis. Hum Reprod 2002, 17:1895-1900.
70. Evans S., Moalem-Taylor G., Tracey D.J. Pain and endometriosis. Pain 2007, 132(Suppl 1):S22-S25.
71. Kunz G., Beil D., Huppert P., et al. Adenomyosis in endometriosis-prevalence and impact on fertility. Evidence from magnetic resonance imaging. Hum Reprod 2005, 20:2309-2316.
72. Paulson J.D., Delgado M. J Soc Laparoendosc Surg 2007, 11:175-181.
73. Leiman G., Markowitz S., Veiga-Ferreira M.M., Margolius K.A. Endometriosis of the rectovaginal septum. Diagnosis by fine needle aspiration cytology. Acta Cytol 1986, 30:313-316.
74. Nisolle M., Casanas-Roux F., Donnez J. Histogenesis of peritoneal endometriosis. Endometriosis: Advanced Management and Surgical Techniques 1995, 19-25. Springer-Verlag, New York. C.R. Nezhat, G.S. Berger, F.R. Nezhat (Eds.).
75. Evers J. The second look laparoscopy for the evaluation of the results of medical treatment of endometriosis should not be performed during ovarian suppression. Fertil Steril 1987, 47:502-504.
76. Stratton P., Winkel C.A., Sinaii N., et al. Location, color, size, depth, and volume may predict endometriosis in lesions resected at surgery. Fertil Steril 2002, 78:743-749.
77. D'Hooghe T.M., Bambra C.S., Raeymaekers B.M., et al. Serial laparoscopies over 30 months show that endometriosis in captive baboons (Papio anubis, Papio cynocephalus) is a progressive disease. Fertil Steril 1996, 65:645-649.
78. Telimaa S., Ronnberg L., Kauppila A. Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis after conservative surgery. Gynecol Endocrinol 1987, 1:363-371.
79. Thomas E.J., Cooke I.D. Impact of gestrinone on the course of asymptomatic endometriosis. Br Med J (Clin Res) 1987, 294:272-274.
80. Cooke I.D., Thomas E.J. The medical treatment of mild endometriosis. Acta Obstet Gynecol Scand 1989, 150:27-30.
81. Mahmood T.A., Templeton A. The impact of treatment on the natural history of endometriosis. Hum Reprod 1990, 5:965-970.
82. Overton C.E., Lindsay P.C., Johal B., et al. A randomized, double-blind, placebo-controlled study of luteal phase dydrogesterone (Duphaston) in women with minimal to mild endometriosis. Fertil Steril 1994, 62:701-707.
83. Sutton C.J., Pooley A.S., Ewen S.P., et al. Follow-up report on a randomized controlled trial of laser laparoscopy in the treatment of pelvic pain associated with minimal to moderate endometriosis. Fertil Steril 1997, 68:1070-1074.
84. Harrison R.F., Barry-Kinsella C. Efficacy of medroxyprogesterone treatment in infertile women with endometriosis: a prospective, randomized, placebo-controlled study. Fertil Steril 2000, 74:24-30.
85. Abbott J., Hawe J., Hunter D., et al. Laparoscopic excision of endometriosis: a randomized, placebo-controlled trial. Fertil Steril 2004, 82:878-884.
86. Redwine D.B. Age-related evolution in color appearance of endometriosis. Fertil Steril 1987, 48:1062-1063.
87. Koninckx P.R., Martin D.C. Deep endometriosis: a consequence of infiltration or retraction or possibly adenomyosis externa?. Fertil Steril 1992, 58:924-928.
88. Vercellini P., Aimi G., Panazza S., et al. Deep endometriosis conundrum: evidence in favor of a peritoneal origin. Fertil Steril 2000, 73:1043-1046.
89. Nisolle-Pochet M., Casanas-Roux F., Donnez J. Histologic study of ovarian endometriosis after hormonal therapy. Fertil Steril 1988, 49:423-426.
90. Alcazar J.L., Garcia-Manero M. Ovarian endometrioma vascularization in women with pelvic pain. Fertil Steril 2007, 87:1271-1276.
91. Ryan I., Schriock E., Taylor R. Isolation, characterization and comparison of human endometrial and endometriosis cells. in vitro. J Clin Endocrinol Metab 1994, 78:642-649.
92. Murphy A., Guzick D., Rock J. Microscopic peritoneal endometriosis. Fertil Steril 1989, 51:1072-1074.
93. Revised American Fertility Society classification of endometriosis:1985. Fertil Steril 1985, 43:1-2.
94. Guzick D., Silliman N., Adamson G., et al. Prediction of pregnancy in infertile women based on the American Society for Reproductive Medicine's revised classification of endometriosis. Fertil Steril 1997, 67:822-829.
95. Hoeger K., Guzick D. An update on the classification of endometriosis. Clin Obstet Gynecol 1999, 42:611-619.
96. Lebovic D., Chao V., Martini J.-F., et al. Interleukin-1β induction of RANTES (regulated upon activation normal T cell expressed and secreted) chemokine gene expression in endometriotic stromal cells depends on an NF-kB site in the proximal promoter. J Clin Endocrinol Metab 2001, 86:4759-4764.
97. Sugimura K., Okizuka H., Imaoka I., et al. Pelvic endometriosis: detection and diagnosis with chemical shift MR imaging. Radiology 1993, 188:435-438.
98. Outwater E., Dunton C. Imaging of the ovary and adnexa: clinical issues and applications of MR imaging. Radiology 1995, 194:1-18.
99. Serra A., Hricak H. Gynecologic imaging: practical applications for magnetic resonance imaging. Curr Opin Obstet Gynecol Fertil 1997, 20:166-181.
100. Abrao M.S., Goncalves M.O., Dias J.A.J., et al. Comparison between clinical examination, transvaginal sonography and magnetic resonance imaging for the diagnosis of deep endometriosis. Hum Reprod 2007, 22:3092-3097.
101. Kupfer M.C., Schwimer S.R., Lebovic J. Transvaginal sonographic appearance of endometrioma: spectrum of findings. J Ultrasound Med 1992, 11:129-133.
102. Asch E., Levine D. Variations in appearance of endometriomas. J Ultrasound Med 2007, 26:993-1002.
103. Broderick K., Feldstein V.A. Ultrasound evaluation of the uterus and endometrium. Curr Probl Obstet Gynecol Fertil 1997, 20:153-164.
104. Barbieri R.L., Niloff J.M., Bast R.C.J., et al. Elevated serum concentrations of CA-125 in patients with advanced endometriois. Fertil Steril 1986, 45:630-634.
105. O'Brien T.J., Tanimoto H., Konishi I., et al. More than 15 years of CA 125: what is known about the antigen, its structure and its function. Int J Biol Markers 1998, 13:188-195.
106. Nagamani M., Kelver M.E., Smith E.R. CA 125 levels in monitoring therapy for endometriosis and in prediction of recurrence. Int J Fertil 1992, 37:227-231.
107. Cheng Y.M., Wang S.T., Chou C.Y. Serum CA-125 in preoperative patients at high risk for endometriosis. Obstet Gynecol 2002, 99:375-380.
108. Somigliana E., Vigano P., Candiani M., et al. Use of serum-soluble intercellular adhesion molecule-1 as a new marker of endometriosis. Fertil Steril 2002, 77:1028-1031.
109. Othman E.E., Hornung D., Salem H.T., et al. Serum cytokines as biomarkers for nonsurgical prediction of endometriosis. Eur J Obstet Gynecol Reprod Biol 2008, 137(2):240-246.
110. Seeber B., Sammel M.D., Fan X., et al. Panel of markers can accurately predict endometriosis in a subset of patients. Fertil Steril 2008, 89(5):1073-1081.
111. Zhang H., Niu Y., Feng J., et al. Use of proteomic analysis of endometriosis to identify different protein expression in patients with endometriosis versus normal controls. Fertil Steril 2006, 86:274-282.
112. Goldstein D., De Cholnoky C., Emans S. Adolescent endometriosis. J Adolesc Health Care 1980, 1:37-41.
113. Takayama K., Zeitoun K., Gunby R.T., et al. Treatment of severe postmenopausal endometriosis with an aromatase inhibitor. Fertil Steril 1998, 69:709-713.
114. Heilier J.F., Donnez O., Van Kerckhove V., et al. Expression of aromatase (P450 aromatase/CYP19) in peritoneal and ovarian endometriotic tissues and deep endometriotic (adenomyotic) nodules of the rectovaginal septum. Fertil Steril 2006, 85:1516-1518.
115. Zeitoun K., Takayama K., Michael M.D., et al. Stimulation of aromatase P450 promoter (II) activity in endometriosis and its inhibition in endometrium are regulated by competitive binding of steroidogenic factor-1 and chicken ovalbumin upstream promoter transcription factor to the same cis-acting element. Mol Endocrinol 1999, 13:239-253.
116. Tsai S.J., Wu M.H., Lin C.C., et al. Regulation of steroidogenic acute regulatory protein expression and progesterone production in endometriotic stromal cells. J Clin Endocrinol Metab 2001, 86:5765-5773.
117. Zeitoun K., Takayama K., Sasano H., et al. Deficient 17beta-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17beta-estradiol. J Clin Endocrinol Metab 1998, 83:4474-4480.
118. Jänne O., Kauppila A., Kokko E., et al. Estrogen and progestin receptors in endometriosis lesions: comparison with endometrial tissue. Am J Obstet Gynecol 1981, 141:562-566.
119. Lessey B., Metzger D., Haney A., et al. Immunohistochemical analysis of estrogen and progesterone receptors in endometriosis: comparison with normal endometrium during the menstrual cycle and the effect of medical therapy. Fertil Steril 1989, 51:409-415.
120. Bergqvist A., Ferno M. Oestrogen and progesterone receptors in endometriotic tissue and endometrium: comparison of different cycle phases and ages. Hum Reprod 1993, 8:2211-2217.
121. Brandenberger A.W., Lebovic D.I., Tee M.K., et al. Estrogen receptor (ER)α and ERβ isoforms in normal endometrial and endometriosis-derived stromal cells. Mol Hum Reprod 1999, 5:651-655.
122. Harris H.A., Bruner-Tran K.L., Zhang X., et al. A selective estrogen receptor-beta agonist causes lesion regression in an experimentally induced model of endometriosis. Hum Reprod 2005, 20:936-941.
123. Horie K., Takakura K., Imai K., et al. Immunohistochemical localization of androgen receptor in the human endometrium, decidua, placenta and pathological conditions of the endometrium. Hum Reprod 1992, 7:1461-1466.
124. Selak V., Farquhar C., Prentice A., et al. Danazol for pelvic pain associated with endometriosis. Cochrane Database Syst Rev 2000, CD000068.
125. Dunselman G., Groothuis P., de Goeij A., et al. The mesothelium, Teflon or Velcro? Mesothelium in endometriosis pathogenesis. Hum Reprod 2001, 16:605-607.
126. Dechaud H., Witz C.A., Montoya-Rodriguez I.A., et al. Mesothelial cell-associated hyaluronic acid promotes adhesion of endometrial cells to mesothelium. Fertil Steril 2001, 76:1012-1018.
127. Tseng J., Ryan I., Milan T., et al. Interleukin-6 secretion in vitro is up-regulated in ectopic and eutopic endometrial stromal cells from women with endometriosis. J Clin Endocrinol Metab 1996, 81:1118-1122.
128. Koutsilieris M., Lavergne E., Lemay A. Association of protease activity against IGFBP-3 with peritoneal fluid mitogens: possible implications for the ectopic growth of endometrial cells in women with endometriosis. Anticancer Res 1997, 17:1239-1244.
129. Bruner K., Eisenberg E., Gorstein F., et al. Progesterone and transforming growth factor-beta coordinately regulate suppression of endometrial matrix metalloproteinases in a model of experimental endometriosis. Steroids 1999, 64:648-653.
130. Osteen K., Bruner-Tra K., On D., et al. Paracrine mediators of endometrial matrix metalloproteinase expression: potential targets for progestin-based treatment of endometriosis. Ann N Y Acad Sci 2002, 955:139-146.
131. Badawy S., Cuenca V., Marshall L., et al. Cellular components in peritoneal fluid in infertile patients with and without endometriosis. Fertil Steril 1984, 42:704-708.
132. Hornung D., Dohrn K., Sotlar K., et al. Localization in tissues and secretion of eotaxin by cells from normal endometrium and endometriosis. J Clin Endocrinol Metab 2000, 85:2604-2608.
133. Koninckx P.R., Riittinen L., Seppala M., et al. CA-125 and placental protein 14 concentrations in plasma and peritoneal fluid of women with deeply infiltrating pelvic endometriosis. Fertil Steril 1992, 57:523-530.
134. Anderson D.J., Hill J.A. Interleukin-1 and endometriosis. Fertil Steril 1987, 48:894-895.
135. Rier S., Parsons A., Becker J. Altered interleukin-6 production by peritoneal leukocytes from patients with endometriosis. Fertil Steril 1994, 61:294-299.
136. Ryan I., Tseng J., Schriock E., et al. Interleukin-8 concentrations are elevated in peritoneal fluid of women with endometriosis. Fertil Steril 1995, 63:929-932.
137. Akoum A., Lemay A., McColl S.R., et al. Increased monocyte chemotactic protein-1 level and activity in the peripheral blood of women with endometriosis. Le Groupe d'Investigation en Gynecologie. Am J Obstet Gynecol 1996, 175:1620-1625.
138. Halme J., White C., Kauma S., et al. Peritoneal macrophages from patients with endometriosis release growth factor activity in vitro. J Clin Endocrinol Metab 1988, 66:1044-1049.
139. Khorram O., Taylor R., Ryan I., et al. Peritoneal fluid concentrations of the cytokine RANTES correlate with the severity of endometriosis. Am J Obstet Gynecol 1993, 169:1545-1549.
140. Daniel Y., Geva E., Amit A., et al. Do soluble cell adhesion molecules play a role in endometriosis?. Am J Reprod Immunol 2000, 43:160-166.
141. Oosterlynck D., Meuleman C., Waer M., et al. Transforming growth factor-beta activity is increased in peritoneal fluid from women with endometriosis. Obstet Gynecol 1994, 83:287-292.
142. Shifren J., Tseng J., Zaloudek C., et al. Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. J Clin Endocrinol Metab 1996, 81:3112-3118.
143. De Leon F.D., Vijayakumar R., Brown M., et al. Peritoneal fluid volume, estrogen, progesterone, prostaglandin, and epidermal growth factor concentrations in patients with and without endometriosis. Obstet Gynecol 1986, 68:189-194.
144. Huang J., Papasakelariou C., Dawood M. Epidermal growth factor and basic fibroblast growth factor in peritoneal fluid of women with endometriosis. Fertil Steril 1996, 65:931-944.
145. Keenan J., Chen T., Chadwell N. IL-1β, TNFα, and IL-2 in peritoneal fluid and macrophage-conditioned media of women with endometriosis. Am J Reprod Immunol 1995, 34:381-385.
146. Gazvani M.R., Bates M.D., Vince G.S., et al. Peritoneal fluid concentrations of interleukin-4 in relation to the presence of endometriosis, its stage and the phase of the menstrual cycle. Acta Obstet Gynecol Scand 2001, 80:361-363.
147. Mazzeo D., Vigano P., Di Blasio A.M., et al. Interleukin-12 and its free p40 subunit regulate immune recognition of endometrial cells: potential role in endometriosis. J Clin Endocrinol Metab 1998, 83:911-916.
148. McLaren J., Dealtry G., Prentice A., et al. Decreased levels of the potent regulator of monocyte/macrophage activation, interleukin-13, in the peritoneal fluid of patients with endometriosis. Hum Reprod Update 1997, 12:1307-1310.
149. Zhang X., Wen J., Deng L., et al. Decreased levels of peritoneal interleukin-1 receptor antagonist in patients with endometriosis and disease-related dysmenorrhea. Fert Steril 2007, 88:594-599.
150. Vaskivuo T., Stenback F., Karhumaa P., et al. Apoptosis and apoptosis-related proteins in human endometrium. Mol Cell Endocrinol 2000, 165:75-83.
151. Meresman G., Vighi S., Buquet R.A., et al. Apoptosis and expression of Bcl-2 and Bax in eutopic endometrium from women with endometriosis. Fertil Steril 2000, 74:760-766.
152. Dmowski W., Ding J., Shen J., et al. Apoptosis in endometrial glandular and stromal cells in women with and without endometriosis. Hum Reprod 2001, 16:1802-1808.
153. Harada T., Taniguchi F., Izawa M., et al. Apoptosis and endometriosis. Front Biosci 2007, 12:3140-3151.
154. Folkman J. The role of angiogenesis in tumor growth. Semin Cancer Biol 1992, 3:65-71.
155. Hanahan D. Signaling vascular morphogenesis and maintenance. Science 1997, 277:48-50.
156. Taylor R., Ryan I., Moore E., et al. Angiogenesis and macrophage activation in endometriosis. Ann of N Y Acad Sci 1997, 828:194-207.
157. Donnez J., Smoes P., Gillerot S., et al. Vascular endothelial growth factor (VEGF) in endometriosis. Hum Reprod 1998, 13:1686-1690.
158. Ryan I.P., Taylor R.N. Endometriosis and infertility: new concepts. Obstet Gynecol Surv 1997, 52:365-371.
159. Lebovic D., Bentzien F., Chao V., et al. Induction of an angiogenic phenotype in endometriotic stromal cell cultures by interleukin-1beta. Mol Hum Reprod 2000, 6:269-275.
160. Knudson A. Genetics and etiology of human cancer. Adv Hum Genet 1977, 8:1-66.
161. Kennedy S. The genetics of endometriosis. Eur J Obstet Gynecol Reprod Biol 1999, 82:129-133.
162. Ria R., Loverro G., Vacca A., et al. Angiogenesis extent and expression of matrix metalloproteinase-2 and -9 agree with progression of ovarian endometriomas. Eur J Clin Invest 2002, 32:199-206.
163. Oosterlynck D., Meuleman C., Sobis H., et al. Angiogenic activity of peritoneal fluid from women with endometriosis. Fertil Steril 1993, 59:778-782.
164. Sugino N., Kashida S., Karube-Harada A., et al. Expression of vascular endothelial growth factor (VEGF) and its receptors in human endometrium throughout the menstrual cycle and in early pregnancy. Reproduction 2002, 123:379-387.
165. Mueller M., Vigne J.-L., Minchenko A., et al. Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors α and β. Proc Natl Acad Sci USA 2000, 97:10972-10977.
166. Mueller M.D., Vigne J.L., Pritts E.A., et al. Progestins activate vascular endothelial growth factor gene transcription in endometrial adenocarcinoma cells. Fertil Steril 2003, 79:386-392.
167. Odukoya O., Ajjan R., Lim K., et al. The pattern of cytokine mRNA expression in ovarian endometriomata. Mol Hum Reprod 1997, 3:393-397.
168. Bergqvist A., Bruse C., Carlberg M., et al. Interleukin 1beta, interleukin-6, and tumor necrosis factor-alpha in endometriotic tissue and in endometrium. Fertil Steril 2001, 75:489-495.
169. Kauma S., Clark M., White C., et al. Production of fibronectin by peritoneal macrophages and concentration of fibronectin in peritoneal fluid from patients with or without endometriosis. Obstet Gynecol 1988, 72:13-18.
170. Matsuzaki S., Canis M., Darcha C., et al. Fibrogenesis in peritoneal endometriosis. A semi-quantitative analysis of type-I collagen. Gynecol Obstet Invest 1999, 47:197-199.
171. Saed G., Zhang W., Chegini N., et al. Transforming growth factor beta isoforms production by human peritoneal mesothelial cells after exposure to hypoxia. Am J Reprod Immunol 2000, 43:285-291.
172. Foyouzi N., Berkkanoglu M., Arici A., et al. Effects of oxidants and antioxidants on proliferation of endometrial stromal cells. Fertil Steril 2004, 82(Suppl 3):1019-1022.
173. Murphy A.A., Santanam N., Morales A.J., et al. Lysophosphatidyl choline, a chemotactic factor for monocytes/T-lymphocytes is elevated in endometriosis. J Clin Endocrinol Metab 1998, 83:2110-2113.
174. Arumugam K., Yip Y.C. De novo formation of adhesions in endometriosis: the role of iron and free radical reactions. Fertil Steril 1995, 64:62-64.
175. Polak G., Koziol-Montewka M., Gogacz M., et al. Total antioxidant status of peritoneal fluid in infertile women. Eur J Obstet Gynecol Reprod Biol 2001, 94:261-263.
176. Alpay Z., Saed G.M., Diamond M.P. Female infertility and free radicals: potential role in adhesions and endometriosis. J Soc Gynecol Investig 2006, 13:390-398.
177. Halme J., Becker S., Haskill S. Altered maturation and function of peritoneal macrophages: possible role in pathogenesis of endometriosis. Am J Obstet Gynecol 1987, 156:783-789.
178. Cirkel U., Ochs H., Mues B., et al. Inflammatory reaction in endometriotic tissue: an immunohistochemical study. Eur J Obstet Gynecol Reprod Biol 1993, 48:43-50.
179. Klein N., Pergola G., Tekmal R. Cytokine regulation of cellular proliferation in endometriosis. Ann NY Acad Sci 1994, 734:322-332.
180. Chegini N. Peritoneal molecular environment, adhesion formation and clinical implication. Front Biosci 2002, 7:91-115.
181. Taylor R., Hornung D., Mueller M., et al. Immunology of endometriosis. Infertil Reprod Med Clin North Am 2002, 145-157.
182. Weed J.C., Arquembourg P.C. Endometriosis: can it produce an autoimmune response resulting in infertility?. Clin Obstet Gynecol 1980, 23:885-893.
183. D'Hooghe T., Hill J.A., Oosterlynck D.J., et al. Effect of endometriosis on white blood cell subpopulations in peripheral blood and peritoneal fluid of baboons. Hum Reprod Update 1996, 11:1736-1740.
184. Iborra A., Palacio J.R., Ulcova-Gallova Z., et al. Autoimmune response in women with endometriosis. Am J Reprod Immunol 2000, 44:236-241.
185. Badawy S., Cuenca V., Kaufman L., et al. The regulation of immunoglobulin production by B cells in patients with endometriosis. Fertil Steril 1989, 51:770-773.
186. Simpson J.L., Malinak L.R., Elias S., et al. HLA associations in endometriosis. Am J Obstet Gynecol 1984, 148:395-397.
187. Maxwell C., Kilpatrick D.C., Haining R., et al. No HLA-DR specificity is associated with endometriosis. Tissue Antigens 1989, 34:145-147.
188. Ota H., Igarashi S. Expression of major histocompatibility complex class II antigen in endometriotic tissue in patients with endometriosis and adenomyosis. Fertil Steril 1993, 60:834-838.
189. Sinaii N., Cleary S.D., Ballweg M.L., et al. High rates of autoimmune and endocrine disorders, fibromyalgia, chronic fatigue syndrome and atopic diseases among women with endometriosis: a survey analysis. Hum Reprod 2002, 17:2715-2724.
190. Hever A., Roth R.B., Hevezi P., et al. Human endometriosis is associated with plasma cells and overexpression of B lymphocyte stimulator. Proc Nat Acad Sci U S A 2007, 104:12451-12456.
191. Mathur S. Autoimmunity in endometriosis: relevance to infertility. Am J Reprod Immunol 2000, 44:89-95.
192. Grosskinsky C., Halme J. Endometriosis: the host response. Bailliere's Clin Obstet Gynaecol 1993, 7:701-713.
193. Viganò P., Gaffuri B., Somigliana E., et al. Expression of intercellular adhesion molecule (ICAM)-1 mRNA and protein is enhanced in endometriosis versus endometrial stromal cells in culture. Mol Hum Reprod 1998, 4:1150-1156.
194. Braun D.P., Dmowski W.P. Endometriosis: abnormal endometrium and dysfunctional immune response. Curr Opin Obstet Gynecol 1998, 10:365-369.
195. Oosterlynck D., Cornillie F., Waer M., et al. Women with endometriosis show a defect in natural killer activity resulting in a decreased cytotoxicity to autologous endometrium. Fertil Steril 1991, 56:45-51.
196. Hornung D., Fujii E., Lim K.-H., et al. HLA-G is not expressed by endometriosis or endometrial tissues. Fertil Steril 2001, 75:814-817.
197. Barrier B.F., Kendall B.S., Ryan C.E., et al. HLA-G is expressed by the glandular epithelium of peritoneal endometriosis but not in eutopic endometrium. Hum Reprod 2006, 21:864-869.
198. Garrido N., Navarro J., Garcia-Velasco J., et al. The endometrium versus embryonic quality in endometriosis-related infertility. Hum Reprod Update 2002, 8:95-103.
199. Bodri D., Colodron M., Vidal R., et al. Prognostic factors in oocyte donation: an analysis through egg-sharing recipient pairs showing a discordant outcome. Fertil Steril 2007, 88(6):1548-1553.
200. Xu H., Schultze-Mosgau A., Agic A., et al. Regulated upon activation, normal T cell expressed and secreted (RANTES) and monocyte chemotactic protein 1 in follicular fluid accumulate differentially in patients with and without endometriosis undergoing in vitro fertilization. Fertil Steril 2006, 86:1616-1620.
201. Oral E., Arici A., Olive D.L., et al. Peritoneal fluid from women with moderate or severe endometriosis inhibits sperm motility: the role of seminal fluid components. Fertil Steril 1996, 66:787-792.
202. Mastroianni L. The fallopian tube and reproductive health. J Pediatr Adolesc Gynecol 1999, 12:121-126.
203. Yamashita Y., Ueda M., Takehara M., et al. Influence of severe endometriosis on gene expression of vascular endothelial growth factor and interleukin-6 in granulosa cells from patients undergoing controlled ovarian hyperstimulation for in vitro fertilization-embryo transfer. Fertil Steril 2002, 78:865-871.
204. Kerin J., Surrey E., Daykhovsky L., et al. Development and application of a falloposcope for transvaginal endoscopy of the fallopian tube. J Laparoendosc Surg 1990, 1:47-56.
205. Kerin J., Daykhovsky L., Segalowitz J., et al. Falloposcopy: a microendoscopic technique for visual exploration of the human fallopian tube from the uterotubal ostium to the fimbria using a transvaginal approach. Fertil Steril 1990, 54:390-400.
206. Klein N., Pergola G., Rao-Tekmal R., et al. Enhanced expression of resident leukocyte interferon gamma mRNA in endometriosis. Am J Reprod Immunol 1993, 30:74-81.
207. Garcia T., Benhamou B., Gofflo D., et al. Switching agonistic, antagonistic, and mixed transcriptional responses to 11 beta-substituted progestins by mutation of the progesterone receptor. Mol Endocrinol 1992, 6:2071-2078.
208. Lessey B.A., Castelbaum A.J., Sawin S.W., et al. Aberrant integrin expression in the endometrium of women with endometriosis. J Clin Endocrinol Metab 1994, 79:643-649.
209. Sharpe K.L., Zimmer R.L., Griffin W.T., et al. Polypeptides synthesized and released by human endometriosis differ from those of the uterine endometrium in cell and tissue explant culture. Fertil Steril 1993, 60:839-851.
210. Taylor H.S., Bagot C., Kardana A., et al. HOX gene expression is altered in the endometrium of women with endometriosis. Hum Reprod 1999, 14:1328-1331.
211. Syrop C.H., Halme J. Peritoneal fluid environment and infertility. Fertil Steril 1987, 48:1-9.
212. Metzger D.A., Olive D.L., Stohs G.F., et al. Association of endometriosis and spontaneous abortion: effect of control group selection. Fertil Steril 1986, 45:18-22.
213. Vercammen E.E., D'Hooghe T.M. Endometriosis and recurrent pregnancy loss. Semin Reprod Med 2000, 18:363-368.
214. Barnhart K., Dunsmoor-Su R., Coutifaris C. Effect of endometriosis on in vitro fertilization. Fertil Steril 2002, 77:1148-1155.
215. Melin A., Sparen P., Persson I., et al. Endometriosis and the risk of cancer with special emphasis on ovarian cancer. Hum Reprod 2006, 21:1237-1242.
216. Dinulescu D.M., Ince T.A., Quade B.J., et al. Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer. Nat Med 2005, 11:63-70.
217. Lundeen S.J., Horwitz C.A., Larson C.J., et al. Abnormal cervicovaginal smears due to endometriosis: a continuing problem. Diagn Cytopathol 2002, 26:35-40.
218. Sutton C., Ewen S., Whitelaw N., et al. Prospective, randomized, double-blind, controlled trial of laser laparoscopy in the treatment of pelvic pain associated with minimal, mild, and moderate endometriosis. Fertil Steril 1994, 62:696-700.
219. Jones K., Haines P., Sutton C. Long-term follow-up of a controlled trial of laser laparoscopy for pelvic pain. JSLS 2001, 5:111-115.
220. Yang J., Van Dijk-Smith J.P., Van Vugt D.A., et al. Fluorescence and photosensitization of experimental endometriosis in the rat after systemic 5-aminolevulinic acidadministration: a potential new approach to the diagnosis and treatment of endometriosis. Am J Obstet Gynecol 1996, 174:154-160.
221. Buchweitz O., Staebler A., Tio J., et al. Detection of peritoneal endometriotic lesions by autofluorescence laparoscopy. Am J Obstet Gynecol 2006, 195:949-954.
222. Jones K., Owen E., Berresford A., et al. Endometrial adenocarcinoma arising from endometriosis of the rectosigmoid colon. Gynecol Oncol 2002, 86:220-222.
223. Hart R.J., Hickey M., Maouris P., et al. Excisional surgery versus ablative surgery for ovarian endometriomata. Cochrane Database Syst Rev 2005, CD004992.
224. Matorras R., Elorriaga M.A., Pijoan J.I., et al. Recurrence of endometriosis in women with bilateral adnexectomy (with or without total hysterectomy) who received hormone replacement therapy. Fertil Steril 2002, 77:303-308.
225. Vercellini P., Frontino G., De Giorgi O., et al. Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen. Fertil Steril 2003, 80:560-563.
226. Rice V. Conventional medical therapies for endometriosis. Ann N Y Acad Sci 2002, 955:343-352.
227. Howard F. An evidence-based medicine approach to the treatment of endometriosis-associated chronic pelvic pain: placebo-controlled studies. J Am Assoc Gynecol Laparosc 2000, 7:477-488.
228. Sagsveen M., Farmer J.E., Prentice A., et al. Gonadotrophin-releasing hormone analogues for endometriosis: bone mineral density. Cochrane Database Syst Rev 2003, CD001297.
229. Surrey E., Hornstein M.D. Prolonged GnRH agonist and add-back therapy for symptomatic endometriosis: long-term follow-up. Obstet Gynecol 2002, 99:709-719.
230. Bedaiwy M.A., Casper R.F. Treatment with leuprolide acetate and hormonal add-back for up to 10 years in stage IV endometriosis patients with chronic pelvic pain. Fertil Steril 2006, 86:220-222.
231. Hornstein M.D., Yuzpe A.A., Burry K.A., et al. Prospective randomized double-blind trial of 3 versus 6 months of nafarelin therapy for endometriosis associated pelvic pain. Fertil Steril 1995, 63:955-962.
232. Crosignani P.G., Luciano A., Ray A., et al. Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain. Hum Reprod 2006, 21:248-256.
233. Schlaff W.D., Carson S.A., Luciano A., et al. Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain. Fertil Steril 2006, 85:314-325.
234. Kauppila A., Ronnberg L. Naproxen sodium in dysmenorrhea secondary to endometriosis. Obstet Gynecol 1985, 65:379-383.
235. Chishima F., Hayakawa S., Sugita K., et al. Increased expression of cyclooxygenase-2 in local lesions of endometriosis patients. Am J Reprod Immunol 2002, 48:50-56.
236. Daniels S.E., Talwalker S., Torri S., et al. Valdecoxib, a cyclooxygenase-2-specific inhibitor, is effective in treating primary dysmenorrhea. Obstet Gynecol 2002, 100:350-358.
237. Allen C., Hopewell S., Prentice A. Non-steroidal anti-inflammatory drugs for pain in women with endometriosis. Cochrane Database Syst Rev 2005, CD004753.
238. Mahler C. Is disease flare a problem?. Cancer 1993, 72:3799-3802.
239. Kupker W., Felberbaum R.E., Krapp M., et al. Use of GnRH antagonists in the treatment of endometriosis. Reprod Biomed Online 2002, 5:12-16.
240. Rose P.G., Alvarez B., Maclennan G.T. Exacerbation of endometriosis as a result of premenopausal tamoxifen exposure. Am J Obstet Gynecol 2000, 183:507-508.
241. Buelke-Sam J., Cohen I.R., Wierda D., et al. The selective estrogen receptor modulator, raloxifene: a segment II/III delivery study in rats. Reprod Toxicol 1998, 12:271-288.
242. Stratton P., Sinaii N., Segars J.H., et al. Return of chronic pelvic pain from endometriosis after raloxifene treatment. A randomized controlled trial. Obstet Gynecol 2008, 111:88-96.
243. Vignali M., Infantino M., Matrone R., et al. Endometriosis: novel etiopathogenetic concepts and clinical perspectives. Fertil Steril 2002, 78:665-678.
244. Remorgida V., Abbamonte L.H., Ragni N., et al. Letrozole and desogestrel-only contraceptive pill for the treatment of stage IV endometriosis. Aust N Z J Obstet Gynaecol 2007, 47:222-225.
245. Chabbert-Buffet N., Meduri G., Bouchard P., et al. Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications. Hum Reprod Update 2005, 11:293-307.
246. Kettel L., Murphy A., Mortola J., et al. Endocrine responses to long-term administration of the antiprogesterone RU486 in patients with pelvic endometriosis. Fertil Steril 1991, 56:402-407.
247. Kettel L., Murphy A., Morales A., et al. Preliminary report on the treatment of endometriosis with low-dose mifepristone (RU 486). Am J Obstet Gynecol 1998, 178:1151-1156.
248. Newfield R., Spitz I., Isacson C., et al. Long-term mifepristone (RU486) therapy resulting in massive benign endometrial hyperplasia. Clin Endocrinol (Oxf) 2001, 54:399-404.
249. Roberts C.P., Murphy A.A., Santanam N., et al. The effect of RU 486 and related compounds on cultured macrophage differentiation and function. Am J Obstet Gynecol 1996, 175:248-257. discussion 57-59.
250. Hornung D., Waite L.L., Ricke E.A., et al. Nuclear peroxisome proliferator-activated receptors alpha and gamma have opposing effects on monocyte chemotaxis in endometriosis. J Clin Endocrinol Metab 2001, 86:3108-3114.
251. Hornung D., Chao V.A., Vigne J.L., et al. Thiazolidinedione inhibition of peritoneal inflammation. Gynecol Obstet Invest 2003, 55:20-24.
252. Ohama Y., Harada M., Iwabe T., et al. Peroxisome proliferator-activated receptor-gamma ligand reduced tumor necrosis factor-alpha-induced interleukin-8 production and growth in endometriotic stromal cells. Fert Steril 2007, 89(2):311-317.
253. Aytan H., Caliskan A.C., Demirturk F., et al. Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone reduces the size of experimental endometriosis in the rat model. Aust N Z J Obstet Gynaecol 2007, 47:321-325.
254. Demirturk F., Aytan H., Caliskan A.C., et al. Effect of peroxisome proliferator-activated receptor-gamma agonist rosiglitazone on the induction of endometriosis in an experimental rat model. J Soc Gynecol Investig 2006, 13:58-62.
255. Lebovic D.I., Kir M., Casey C.L. Peroxisome proliferator-activated receptor-gamma induces regression of endometrial explants in a rat model of endometriosis. Fertil Steril 2004, 82(Suppl 3):1008-1013.
256. Lebovic D.I., Mwenda J.M., Chai D.C., et al. PPAR-gamma receptor ligand induces regression of endometrial explants in baboons: a prospective, randomized, placebo- and drug-controlled study. Fertil Steril 2007, 88:1108-1119.
257. Altintas D., Kokcu A., Tosun M., et al. Efficacy of recombinant human interferon α-2b on experimental endometriosis. Eur J Obstet Gynecol 2008, 139(1):95-99.
258. Altintas D., Kokcu A., Kandemir B., et al. Efficacy of eimiquimod, an immunomodulatory agent, on experimental endometriosis. Fertil Steril 2008, 90(2):401-405.
259. Aytan H., Caglar P., Uygur D., et al. Effect of the immunomodulator leflunomide on the induction of endometriosis in an experimental rat model. Fertil Steril 2007, 87:698-701.
260. Ocal G., Kokcu A., Cetinkaya M.B., et al. Efficacy of levamisole on experimental endometriosis. Int J Gynaecol Obstet 2007, 99:38-42.
261. D'Hooghe T., Cunco S., Nugent N., et al. Recombinant human TNF binding protein-1 (r-hTBP-1) inhibits the development of endometriosis in baboons: a prospective, randomized, placebo- and drug-controlled study (abstract). Fertil Steril 2001, 76(suppl 3):S1.
262. Falconer H., Mwenda J.M., Chai D.C., et al. Effects of anti-TNF-mAb treatment on pregnancy in baboons with induced endometriosis. Fertil Steril 2008, 89(5 Suppl):1537-1545.
263. Hastings J.M., Licence D.R., Burton G.J., et al. Soluble vascular endothelial growth factor receptor 1 inhibits edema and epithelial proliferation induced by 17beta-estradiol in the mouse uterus. Endocrinology 2003, 144:326-334.
264. Fedele L., Bianchi S., Zanconato G., et al. Use of a levonorgestrel-releasing intrauterine device in the treatment of rectovaginal endometriosis. Fertil Steril 2001, 75:485-488.
265. Petta C.A., Ferriani R.A., Abrao M.S., et al. Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis. Hum Reprod 2005, 20:1993-1998.
266. Yavuz E., Oktem M., Esinler I., et al. Genistein causes regression of endometriotic implants in the rat model. Fertil Steril 2007, 88:1129-1134.
267. Oktem M., Esinler I., Eroglu D., et al. High-dose atorvastatin causes regression of endometriotic implants: a rat model. Hum Reprod 2007, 22:1474-1480.
268. Wu Y., Guo S.W. Suppression of IL-1beta-induced COX-2 expression by trichostatin A (TSA) in human endometrial stromal cells. Eur J Obstet Gynecol Reprod Biol 2007, 135:88-93.
269. Razzi S., Luisi S., Calonaci F., et al. Efficacy of vaginal danazol treatment in women with recurrent deeply infiltrating endometriosis. Fertil Steril 2007, 88:789-794.
270. Ponpuckdee J., Taneepanichskul S. The effects of implanon in the symptomatic treatment of endometriosis. J Med Assoc Thai 2005, (88(Suppl 2):S7-10.
271. Nasu K., Nishida M., Ueda T., et al. Application of the nuclear factor-kappaB inhibitor BAY 11-7085 for the treatment of endometriosis: an in vitro study. Am J Physiol Endocrinol Metab 2007, 293:E16-23.
272. Laschke M.W., Elitzsch A., Scheuer C., et al. Rapamycin induces regression of endometriotic lesions by inhibiting neovascularization and cell proliferation. Br J Pharmacol 2006, 149:137-144.
273. Dong-xia Y., Wen-Guant M.A., Fan Q.U., et al. Compararative study on the efficacy of yiweining and gestrinone for post-operational treatment of stage III endometriosis. Chin J Integr Med 2006, 12:218-220.
274. Kohama T., Herai K., Inoue M. Effect of French maritime pine bark extract on endometriosis as compared with leuprorelin acetate. J Reprod Med 2007, 52:703-708.
275. Wieser F., Cohen M., Gaeddert A., et al. Evolution of medical treatment for endometriosis: back to the roots?. Hum Reprod Update 2007, 13:487-499.
276. Marcoux S., Maheux R., Berube S. Laparoscopic surgery in infertile women with minimal or mild endometriosis. Canadian Collaborative Group on Endometriosis. N Engl J Med 1997, 337:217-222.
277. Olive D., Pritts E. The treatment of endometriosis: a review of the evidence. Ann N Y Acad Sci 2002, 955:360-372.
278. Falcone T., Goldberg J., Miller K. Endometriosis: medical and surgical intervention. Curr Opin Obstet Gynecol 1996, 8:178-183.
279. Loh F.H., Tan A.T., Kumar J., et al. Ovarian response after laparoscopic ovarian cystectomy for endometriotic cysts in 132 monitored cycles. Fertil Steril 1999, 72:316-321.
280. Hemmings R., Bissonnette F., Bouzayen R. Results of laparoscopic treatments of ovarian endometriomas: laparoscopic ovarian fenestration and coagulation. Fertil Steril 1998, 70:527-529.
281. Canis M., Pouly J.L., Tamburro S., et al. Ovarian response during IVF-embryo transfer cycles after laparoscopic ovarian cystectomy for endometriotic cysts of >3 cm in diameter. Hum Reprod 2001, 16:2583-2586.
282. Beretta P., Franchi M., Ghezzi F., et al. Randomized clinical trial of two laparoscopic treatments of endometriomas: cystectomy versus drainage and coagulation. Fertil Steril 1998, 70:1176-1180.
283. Donnez J., Chantraine F., Nisolle M. The efficacy of medical and surgical treatment of endometriosis-associated infertility: arguments in favour of a medico-surgical approach. Hum Reprod 2002, 8:89-94.
284. Hughes E., Fedorkow D., Collins J., et al. Ovulation suppression for endometriosis. Cochrane Database Syst Rev 2000, CD000155.
285. Deaton J.L., Gibson M., Blackmer K.M., et al. A randomized, controlled trial of clomiphene citrate and intrauterine insemination in couples with unexplained infertility or surgically corrected endometriosis. Fertil Steril 1990, 54:1083-1088.
286. Tummon I.S., Asher L.J., Martin J.S., et al. Randomized controlled trial of superovulation and insemination for infertility associated with minimal or mild endometriosis. Fertil Steril 1997, 68:8-12.
287. Fedele L., Bianchi S., Marchini M., et al. Superovulation with human menopausal gonadotropins in the treatment of infertility associated with minimal or mild endometriosis: a controlled randomized study. Fertil Steril 1992, 58:28-31.
288. Soliman S., Daya S., Collins J., et al. A randomized trial of in vitro fertilization versus conventional treatment for infertility. Fertil Steril 1993, 59:1239-1244.
289. Kodama H., Fukuda J., Karube H., et al. Benefit of in vitro fertilization treatment for endometriosis-associated infertility. Fertil Steril 1996, 66:974-979.
290. Ling F. Randomized controlled trial of depot leuprolide in patients with chronic pelvic pain and clinically suspected endometriosis. Pelvic Pain Study Group. Obstet Gynecol 1999, 93:51-58.
291. Attar E., Bulun S.E. Aromatase inhibitors: the next generation of therapeutics for endometriosis?. Fertil Steril 2006, 85(5):1307-1318.
292. Brosens I., Puttemans P., Campo R., et al. Non-invasive methods of diagnosis of endometriosis. Curr Opin Obstet Gynecol 2003, 15(6):519-522.
293. Buchweitz O., Staebler A., Tio J., Kiesel L. Detection of peritoneal endometriotic lesions by autofluorescence laparoscopy. Am J Obstet Gynecol 2006, 195(4):949-954.
294. De Hondt A., Meuleman C., Tomassetti C., et al. Endometriosis and assisted reproduction: the role for reproductive surgery?. Curr Opin Obstet Gynecol 2006, 18(4):374-379.
295. DiZerega G.S., Barber D.L., Hodgen G.D. Endometriosis the role of ovarian steroids in initiation, maintenance and suppression. Fertil Steril 1980, 33:649-653.
296. Giudice L.C., Kao L.C. Endometriosis. Lancet 2004, 364(9447):1789-1799.
297. Halme J., Becker S., Haskell S. Altered maturation and function of peritoneal macrophages possible role of pathogenesis of endometriosis. Am J Obstet Gynecol 1987, 56:783-789.
298. Jacobson T.Z., Barlow D.H., Koninckx P.R., et al. Laparoscopic surgery for subfertility associated with endometriosis. Cochrane Database Syst Rev 2002, CD001398.
299. Jaffe R., Pierson R.A., Abramowicz J.S. Imaging in infertility and reproductive endocrinology 1994, Lippincott, Philadelphia.
300. Kao L.C., Germeyer A., Tulac S., et al. Expression profiling of endometrium from women with endometriosis reveals candidate genes for disease-based implantation failure and infertility. Endocrinology 2003, 144(7):2870-2881.
301. Lebovic D.I., Mueller M.D., Taylor R.N. Immunobiology of endometriosis. Fertil Steril 2001, 75(1):1-10.
302. Marcoux S., Maheux R., Berube S., et al. Canadian Collaboration Group on Endometriosis. Laparoscopic surgery in infertile women with minimal or mild endometriosis. N Engl J Med 1997, 377:212-222.
303. Sampson J.A. Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol 1927, 71:422-469.
304. Simsa P., Mihalyi A., Kyama C.M., et al. Selective estrogen-receptor modulators and aromatase inhibitors: promising new medical therapies for endometriosis?. Women's Health 2007, 3:617-628.
305. Somigliana E., Vigano P., Parazzini F., et al. Association between endometriosis and cancer: a comprehensive review and a critical analysis of clinical and epidemiological evidence. Gynecol Oncol 2006, 101(2):331-341.
306. Vercellini P., Abbiati A., Daguati R., et al. Endometriosis: current and future medical therapies. Best Pract Res Clin Obstet Gynaecol 2008, 22(2):275-306.